The DOI matches its Crossref record; 144 of the 144 references it cites were found in a registry or an index.
Wnt/β-catenin signalling in prostate cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
Siegel, R., Naishadham, D., & Jemal, A. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20138 · Cited by 10,679
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
MacDonald, B. T., Tamai, K., & He, X. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.06.016 · Cited by 5,583
Wnt/β-Catenin Signaling in Development and Disease
Clevers, H. (2006) · Cell · doi:10.1016/j.cell.2006.10.018 · Cited by 5,568
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
Tomlins, S. A., Rhodes, D. R., Perner, S., Dhanasekaran, S. M., Mehra, R., Sun, X.-W., Varambally, S., Cao, X., Tchinda, J., Kuefer, R., et al. (2005) · Science · doi:10.1126/science.1117679 · Cited by 3,846
Cadherin Cell Adhesion Receptors as a Morphogenetic Regulator
Takeichi, M. (1991) · Science · doi:10.1126/science.2006419 · Cited by 3,284
Functional interaction of β-catenin with the transcription factor LEF-1
Behrens, J., von Kries, J. P., Kühl, M., Bruhn, L., Wedlich, D., Grosschedl, R., & Birchmeier, W. (1996) · Nature · doi:10.1038/382638a0 · Cited by 2,912
The selectivity of protein kinase inhibitors: a further update
Bain, J., Plater, L., Elliott, M., Shpiro, N., Hastie, C. J., Mclauchlan, H., Klevernic, I., Arthur, J. S. C., Alessi, D. R., & Cohen, P. (2007) · Biochemical Journal · doi:10.1042/bj20070797 · Cited by 2,520
Scher, H. I., Halabi, S., Tannock, I., Morris, M., Sternberg, C. N., Carducci, M. A., Eisenberger, M. A., Higano, C., Bubley, G. J., Dreicer, R., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.4487 · Cited by 2,241
Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
Huang, S.-M. A., Mishina, Y. M., Liu, S., Cheung, A., Stegmeier, F., Michaud, G. A., Charlat, O., Wiellette, E., Zhang, Y., Wiessner, S., et al. (2009) · Nature · doi:10.1038/nature08356 · Cited by 2,037
XTcf-3 Transcription Factor Mediates β-Catenin-Induced Axis Formation in Xenopus Embryos
Molenaar, M., van de Wetering, M., Oosterwegel, M., Peterson-Maduro, J., Godsave, S., Korinek, V., Roose, J., Destrée, O., & Clevers, H. (1996) · Cell · doi:10.1016/s0092-8674(00)80112-9 · Cited by 1,824
Wnt signalling and its impact on development and cancer
Klaus, A., & Birchmeier, W. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2389 · Cited by 1,595
Secreted antagonists of the Wnt signalling pathway
Kawano, Y., & Kypta, R. (2003) · Journal of Cell Science · doi:10.1242/jcs.00623 · Cited by 1,584
Self-citationCaught up in a Wnt storm: Wnt signaling in cancer
Giles, R. H., van Es, J. H., & Clevers, H. (2003) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(03)00005-2 · Cited by 1,482
Small molecule–mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer
Chen, B., Dodge, M. E., Tang, W., Lu, J., Ma, Z., Fan, C.-W., Wei, S., Hao, W., Kilgore, J., Williams, N. S., et al. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.137 · Cited by 1,383
Cell adhesion and signalling by cadherins and Ig-CAMs in cancer
Cavallaro, U., & Christofori, G. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1276 · Cited by 1,311
Association of the APC Gene Product with β-Catenin
Rubinfeld, B., Souza, B., Albert, I., Müller, O., Chamberlain, S. H., Masiarz, F. R., Munemitsu, S., & Polakis, P. (1993) · Science · doi:10.1126/science.8259518 · Cited by 1,223
Association of the APC Tumor Suppressor Protein with Catenins
Su, L.-K., Vogelstein, B., & Kinzler, K. W. (1993) · Science · doi:10.1126/science.8259519 · Cited by 1,188
Function and biological roles of the Dickkopf family of Wnt modulators
Niehrs, C. (2006) · Oncogene · doi:10.1038/sj.onc.1210054 · Cited by 995
A small molecule inhibitor of β-catenin/cyclic AMP response element-binding protein transcription
Emami, K. H., Nguyen, C., Ma, H., Kim, D. H., Jeong, K. W., Eguchi, M., Moon, R. T., Teo, J.-L., Oh, S. W., Kim, H. Y., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404875101 · Cited by 874
A new secreted protein that binds to Wnt proteins and inhibits their activites
Hsieh, J.-C., Kodjabachian, L., Rebbert, M. L., Rattner, A., Smallwood, P. M., Samos, C. H., Nusse, R., Dawid, I. B., & Nathans, J. (1999) · Nature · doi:10.1038/18899 · Cited by 750
Mining the Wnt pathway for cancer therapeutics
Barker, N., & Clevers, H. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2154 · Cited by 743
Bovolenta, P., Esteve, P., Ruiz, J. M., Cisneros, E., & Lopez-Rios, J. (2008) · Journal of Cell Science · doi:10.1242/jcs.026096 · Cited by 655
Small-molecule antagonists of the oncogenic Tcf/β-catenin protein complex
Lepourcelet, M., Chen, Y.-N. P., France, D. S., Wang, H., Crews, P., Petersen, F., Bruseo, C., Wood, A. W., & Shivdasani, R. A. (2004) · Cancer Cell · doi:10.1016/s1535-6108(03)00334-9 · Cited by 653
Interplay of Cadherin-Mediated Cell Adhesion and Canonical Wnt Signaling
Heuberger, J., & Birchmeier, W. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a002915 · Cited by 619
Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis
McManus, E. J., Sakamoto, K., Armit, L. J., Ronaldson, L., Shpiro, N., Marquez, R., & Alessi, D. R. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600633 · Cited by 594
Androgen receptor signaling in prostate cancer development and progression
Tindall, D., & Lonergan, P. (2011) · Journal of Carcinogenesis · doi:10.4103/1477-3163.83937 · Cited by 535
Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α
Thorne, C. A., Hanson, A. J., Schneider, J., Tahinci, E., Orton, D., Cselenyi, C. S., Jernigan, K. K., Meyers, K. C., Hang, B. I., Waterson, A. G., et al. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.453 · Cited by 485
Exploring the specificity of the PI3K family inhibitor LY294002
Gharbi, S. I., Zvelebil, M. J., Shuttleworth, S. J., Hancox, T., Saghir, N., Timms, J. F., & Waterfield, M. D. (2007) · Biochemical Journal · doi:10.1042/bj20061489 · Cited by 462
Mechanisms Underlying the Development of Androgen-Independent Prostate Cancer
Pienta, K. J., & Bradley, D. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0067 · Cited by 430
Interaction of Nuclear Receptors with the Wnt/β-Catenin/Tcf Signaling Axis: Wnt You Like to Know?
Mulholland, D. J., Dedhar, S., Coetzee, G. A., & Nelson, C. C. (2005) · Endocrine Reviews · doi:10.1210/er.2003-0034 · Cited by 377
Beta-catenin mutations in human prostate cancer.
Voeller, H. J., Truica, C., & Gelmann, E. P. (1998) · PubMed · Cited by 371
González-Sancho, J. M., Aguilera, O., García, J. M., Pendás-Franco, N., Peña, C., Cal, S., de Herreros, A. G., Bonilla, F., & Muñoz, A. (2005) · Oncogene · doi:10.1038/sj.onc.1208303 · Cited by 366
Beta-catenin affects androgen receptor transcriptional activity and ligand specificity.
Truica, C. I., Byers, S. W., & Gelmann, E. P. (2000) · PubMed · Cited by 350
Linking β-Catenin to Androgen-signaling Pathway
Yang, F., Li, X., Sharma, M., Sasaki, C. Y., Longo, D. L., Lim, B., & Sun, Z. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111962200 · Cited by 342
Gonsalves, F. C., Klein, K., Carson, B. B., Katz, S., Ekas, L. A., Evans, S., Nagourney, R., Cardozo, T., Brown, A. M. C., & DasGupta, R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017496108 · Cited by 337
Wissmann, C., Wild, P. J., Kaiser, S., Roepcke, S., Stoehr, R., Woenckhaus, M., Kristiansen, G., Hsieh, J., Hofstaedter, F., Hartmann, A., et al. (2003) · The Journal of Pathology · doi:10.1002/path.1449 · Cited by 333
Chien, A. J., Moore, E. C., Lonsdorf, A. S., Kulikauskas, R. M., Rothberg, B. G., Berger, A. J., Major, M. B., Hwang, S. T., Rimm, D. L., & Moon, R. T. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811902106 · Cited by 332
An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells
Bafico, A., Liu, G., Goldin, L., Harris, V., & Aaronson, S. A. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.032 · Cited by 324
Sharma, M., Chuang, W. W., & Sun, Z. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201919200 · Cited by 308
Bisson, I., & Prowse, D. M. (2009) · Cell Research · doi:10.1038/cr.2009.43 · Cited by 308
p53 and MicroRNA-34 Are Suppressors of Canonical Wnt Signaling
Kim, N. H., Kim, H. S., Kim, N.-G., Lee, I., Choi, H.-S., Li, X.-Y., Kang, S. E., Cha, S. Y., Ryu, J. K., Na, J. M., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001744 · Cited by 308
Functional Epigenomics Identifies Genes Frequently Silenced in Prostate Cancer
Lodygin, D., Epanchintsev, A., Menssen, A., Diebold, J., & Hermeking, H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4407 · Cited by 286
Chen, G., Shukeir, N., Potti, A., Sircar, K., Aprikian, A., Goltzman, D., & Rabbani, S. A. (2004) · Cancer · doi:10.1002/cncr.20518 · Cited by 283
Oyama, T., Kanai, Y., Ochiai, A., Akimoto, S., Oda, T., Yanagihara, K., Nagafuchi, A., Tsukita, S., Shibamoto, S., & Ito, F. (1994) · PubMed · Cited by 282
Gupta, S., Iljin, K., Sara, H., Mpindi, J. P., Mirtti, T., Vainio, P., Rantala, J., Alanen, K., Nees, M., & Kallioniemi, O. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0244 · Cited by 278
Persad, S., A.Troussard, A., McPhee, T. R., Mulholland, D. J., & Dedhar, S. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.6.1161 · Cited by 268
Bmi-1 Is a Crucial Regulator of Prostate Stem Cell Self-Renewal and Malignant Transformation
Lukacs, R. U., Memarzadeh, S., Wu, H., & Witte, O. N. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.11.013 · Cited by 268
The opposing roles of Wnt-5a in cancer
McDonald, S. L., & Silver, A. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605174 · Cited by 260
Wnt signaling in stem and cancer stem cells
Wend, P., Holland, J. D., Ziebold, U., & Birchmeier, W. (2010) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2010.09.004 · Cited by 237
Lu, W., Lin, C., Roberts, M. J., Waud, W. R., Piazza, G. A., & Li, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029290 · Cited by 230
Schlange, T., Matsuda, Y., Lienhard, S., Huber, A., & Hynes, N. E. (2007) · Breast Cancer Research · doi:10.1186/bcr1769 · Cited by 229
Yamamoto, H., Oue, N., Sato, A., Hasegawa, Y., Yamamoto, H., Matsubara, A., Yasui, W., & Kikuchi, A. (2010) · Oncogene · doi:10.1038/onc.2009.496 · Cited by 228
Epigenetics in Prostate Cancer: Biologic and Clinical Relevance
Jerónimo, C., Bastian, P. J., Bjartell, A., Carbone, G. M., Catto, J. W. F., Clark, S. J., Henrique, R., Nelson, W. G., & Shariat, S. F. (2011) · European Urology · doi:10.1016/j.eururo.2011.06.035 · Cited by 226
PTEN and GSK3β: key regulators of progression to androgen-independent prostate cancer
Mulholland, D. J., Dedhar, S., Wu, H., & Nelson, C. C. (2006) · Oncogene · doi:10.1038/sj.onc.1209020 · Cited by 216
The Anti-Helminthic Niclosamide Inhibits Wnt/Frizzled1 Signaling
Chen, M., Wang, J., Lu, J., Bond, M. C., Ren, X.-R., Lyerly, H. K., Barak, L. S., & Chen, W. (2009) · Biochemistry · doi:10.1021/bi9009677 · Cited by 213
Identification of a Specific Inhibitor of the Dishevelled PDZ Domain
Shan, J., Shi, D.-L., Wang, J., & Zheng, J. (2005) · Biochemistry · doi:10.1021/bi0512602 · Cited by 213
Nalesso, G., Sherwood, J., Bertrand, J., Pap, T., Ramachandran, M., De Bari, C., Pitzalis, C., & Dell'Accio, F. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201011051 · Cited by 202
Discovery and Characterization of a Small Molecule Inhibitor of the PDZ Domain of Dishevelled
Grandy, D., Shan, J., Zhang, X., Rao, S., Akunuru, S., Li, H., Zhang, Y., Alpatov, I., Zhang, X. A., Lang, R. A., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.009647 · Cited by 201
Biechele, T. L., Kulikauskas, R. M., Toroni, R. A., Lucero, O. M., Swift, R. D., James, R. G., Robin, N. C., Dawson, D. W., Moon, R. T., & Chien, A. J. (2012) · Science Signaling · doi:10.1126/scisignal.2002274 · Cited by 181
Mulholland, D. J., Cheng, H., Reid, K., Rennie, P. S., & Nelson, C. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200135200 · Cited by 172
Wnt-11 promotes neuroendocrine-like differentiation, survival and migration of prostate cancer cells
Uysal-Onganer, P., Kawano, Y., Caro, M., Walker, M. M., Diez, S., Darrington, R. S., Waxman, J., & Kypta, R. M. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-55 · Cited by 171
Self-citationSong, L.-N., Herrell, R., Byers, S., Shah, S., Wilson, E. M., & Gelmann, E. P. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.5.1674-1687.2003 · Cited by 169
Detection and analysis of ?-catenin mutations in prostate cancer
Chesire, D. R., Ewing, C. M., Sauvageot, J., Bova, G. S., & Isaacs, W. B. (2000) · The Prostate · doi:10.1002/1097-0045(20001201)45:4<323::aid-pros7>3.0.co;2-w · Cited by 168
Crosstalk between the Androgen Receptor and β-Catenin in Castrate-Resistant Prostate Cancer
Wang, G., Wang, J., & Sadar, M. D. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1718 · Cited by 168
Liganded Androgen Receptor Interaction with β-Catenin
Pawlowski, J. E., Ertel, J. R., Allen, M. P., Xu, M., Butler, C., Wilson, E. M., & Wierman, M. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200545200 · Cited by 166
Wnt/Fz signaling and the cytoskeleton: potential roles in tumorigenesis
Lai, S.-L., Chien, A. J., & Moon, R. T. (2009) · Cell Research · doi:10.1038/cr.2009.41 · Cited by 161
Regulation of Wnt/β‐catenin signaling by protein kinases
Verheyen, E. M., & Gottardi, C. J. (2010) · Developmental Dynamics · doi:10.1002/dvdy.22019 · Cited by 161
Chesire, D. R., Ewing, C. M., Gage, W. R., & Isaacs, W. B. (2002) · Oncogene · doi:10.1038/sj.onc.1205352 · Cited by 161
Prostate tumor progression is mediated by a paracrine TGF-β/Wnt3a signaling axis
Li, X., Placencio, V. R., Iturregui, J. M., Uwamariya, C., Sharif‐Afshar, A., Koyama, T., Hayward, S. W., & Bhowmick, N. A. (2008) · Oncogene · doi:10.1038/onc.2008.293 · Cited by 159
Joesting, M. S., Perrin, S., Elenbaas, B., Fawell, S. E., Rubin, J. S., Franco, O. E., Hayward, S. W., Cunha, G. R., & Marker, P. C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0824 · Cited by 159
Phosphatidylinositol 3-Kinase Signaling Does Not Activate the Wnt Cascade
Ng, S. S., Mahmoudi, T., Danenberg, E., Bejaoui, I., de Lau, W., Korswagen, H. C., Schutte, M. E. M., & Clevers, H. C. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.078261 · Cited by 153
Targeting protein lipidation in disease
Resh, M. D. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.01.007 · Cited by 152
APC/CTNNB1 (β‐catenin) pathway alterations in human prostate cancers
Gerstein, A. V., Almeida, T. A., Zhao, G., Chess, E., Shih, I., Buhler, K. R., Pienta, K. J., Rubin, M. A., Vessella, R. L., & Papadopoulos, N. (2002) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10037 · Cited by 152
Ligand-dependent inhibition of β-catenin/TCF signaling by androgen receptor
Chesire, D. R., & Isaacs, W. B. (2002) · Oncogene · doi:10.1038/sj.onc.1206049 · Cited by 151
Beta-catenin-related anomalies in apoptosis-resistant and hormone-refractory prostate cancer cells.
TAILLE, A. D. L., Rubin, M. A., Chen, M., Vacherot, F., de Medina, S. G. D., Burchardt, M., Buttyan, R., & Chopin, D. K. (2003) · PubMed · Cited by 151
Hall, C. L., Daignault, S. D., Shah, R. B., Pienta, K. J., & Keller, E. T. (2008) · The Prostate · doi:10.1002/pros.20805 · Cited by 150
Verras, M., Brown, J. D., Li, X., Nusse, R., & Sun, Z. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2370 · Cited by 143
Fiorentino, M., Zadra, G., Palescandolo, E., Fedele, G., Bailey, D., Fiore, C., Nguyen, P. L., Migita, T., Zamponi, R., Vizio, D. D., et al. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.97 · Cited by 139
Modulation of cellular apoptotic potential: contributions to oncogenesis
Stambolic, V., Mak, T. W., & Woodgett, J. R. (1999) · Oncogene · doi:10.1038/sj.onc.1203126 · Cited by 138
Mazor, M., Kawano, Y., Zhu, H., Waxman, J., & Kypta, R. M. (2004) · Oncogene · doi:10.1038/sj.onc.1208068 · Cited by 136
Self-citationYee, D. S., Tang, Y., Li, X., Liu, Z., Guo, Y., Ghaffar, S., McQueen, P., Dash, A., Xie, J., Simoneau, A. R., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-162 · Cited by 136
Bierie, B., Nozawa, M., Renou, J., Shillingford, J. M., Morgan, F., Oka, T., Taketo, M. M., Cardiff, R. D., Miyoshi, K., Wagner, K., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206426 · Cited by 133
Koh, S. S., Li, H., Lee, Y., Widelitz, R. B., Chuong, C., & Stallcup, M. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110865200 · Cited by 132
Saleem, M., Kweon, M., Yun, J., Adhami, V. M., Khan, N., Syed, D. N., & Mukhtar, H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1965 · Cited by 131
Wnt/β-Catenin activation promotes prostate tumor progression in a mouse model
Yu, X., Wang, Y., DeGraff, D. J., Wills, M. L., & Matusik, R. J. (2010) · Oncogene · doi:10.1038/onc.2010.560 · Cited by 130
Interaction and Functional Cooperation between the LIM Protein FHL2, CBP/p300, and β-Catenin
Labalette, C., Renard, C.-A., Neuveut, C., Buendia, M., & Yu, W. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.24.10689-10702.2004 · Cited by 129
de la Roche, M., Rutherford, T. J., Gupta, D. S., Veprintsev, D. B., SAXTY, B. A., Freund, S. M. V., & Bienz, M. (2012) · Nature Communications · doi:10.1038/ncomms1680 · Cited by 128
A Re-evaluation of the “Oncogenic” Nature of Wnt/β-catenin Signaling in Melanoma and Other Cancers
Lucero, O. M., Dawson, D. W., Moon, R. T., & Chien, A. J. (2010) · Current Oncology Reports · doi:10.1007/s11912-010-0114-3 · Cited by 127
Thudi, N. K., Martin, C. K., Murahari, S., Shu, S. T., Lanigan, L. G., Werbeck, J. L., Keller, E. T., McCauley, L. K., Pinzone, J. J., & Rosol, T. J. (2010) · The Prostate · doi:10.1002/pros.21277 · Cited by 126
Suppression of Wnt/β-catenin signaling inhibits prostate cancer cell proliferation
Lü, W., Tinsley, H. N., Keeton, A. B., Qu, Z., Piazza, G. A., & Li, Y. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.10.053 · Cited by 123
Yu, X., Wang, Y., Jiang, M., Bierie, B., Roy‐Burman, P., Shen, M. M., Taketo, M. M., Wills, M. L., & Matusik, R. J. (2008) · The Prostate · doi:10.1002/pros.20877 · Cited by 121
Analysis of Wnt Gene Expression in Prostate Cancer
Zhu, H., Mazor, M., Kawano, Y., Walker, M. M., Leung, H. Y., Armstrong, K., Waxman, J., & Kypta, R. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2704 · Cited by 115
Self-citationComplex regulation of human androgen receptor expression by Wnt signaling in prostate cancer cells
Yang, X., Chen, M.-W., Terry, S., Vacherot, F., Bemis, D. L., Capodice, J. L., Kitajewski, J., TAILLE, A. D. L., Benson, M. C., Guo, Y., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209366 · Cited by 114
Kallakury, B., Sheehan, C. E., Winn-Deen, E. S., Oliver, J., Fisher, H. A. �., Kaufman, R. P., & Ross, J. S. (2001) · Cancer · doi:10.1002/1097-0142(20011201)92:11<2786::aid-cncr10128>3.0.co;2-i · Cited by 109
Inactivation of Apc in the Mouse Prostate Causes Prostate Carcinoma
Bruxvoort, K. J., Charbonneau, H. M., Giambernardi, T. A., Goolsby, J. C., Qian, C.-N., Diegel, C. R., Robinson, D. R., Roy‐Burman, P., Shaw, A. K., Buckner-Berghuis, B. D., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3028 · Cited by 108
Wang, W., Liu, H., Wang, S., Hao, X., & Li, L. (2011) · Cell Research · doi:10.1038/cr.2011.30 · Cited by 107
Li, Y., Wang, L., Zhang, M., Melamed, J., Liu, X., Reiter, R. E., Wei, J., Peng, Y., Zou, X., Pellicer, À., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3380 · Cited by 107
Non-competitive androgen receptor inhibition in vitro and in vivo
Jones, J. O., Bolton, E. C., Huang, Y., Féau, C., Guy, R. K., Yamamoto, K. R., Hann, B. C., & Diamond, M. I. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807282106 · Cited by 106
Mulholland, D. J., Read, J. T., Rennie, P. S., Cox, M., & Nelson, C. C. (2003) · Oncogene · doi:10.1038/sj.onc.1206802 · Cited by 104
Gounari, F., Signoretti, S., Bronson, R. T., Klein, L., Sellers, W. R., Kum, J. B., Siermann, A., Taketo, M. M., von Boehmer, H., & Khazaie, K. (2002) · Oncogene · doi:10.1038/sj.onc.1205562 · Cited by 104
A Useful Approach to Identify Novel Small-Molecule Inhibitors of Wnt-Dependent Transcription
Ewan, K., Pająk, B., Stubbs, M., Todd, H., Barbeau, O. R., Quevedo, C. E., Botfield, H. F., Young, R., Ruddle, R. R., Samuel, L. J., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1028 · Cited by 102
β-Catenin activation synergizes with PTEN loss to cause bladder cancer formation
Ahmad, I., Morton, J. P., Singh, L. B., Radulescu, S., Ridgway, R. A., Patel, S., Woodgett, J. R., Winton, D. J., Taketo, M. M., Wu, X., et al. (2010) · Oncogene · doi:10.1038/onc.2010.399 · Cited by 99
Lupeol, a Novel Androgen Receptor Inhibitor: Implications in Prostate Cancer Therapy
Siddique, H. R., Mishra, S. K., Karnes, R. J., & Saleem, M. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0916 · Cited by 98
K-ras and Wnt Signaling Synergize to Accelerate Prostate Tumorigenesis in the Mouse
Pearson, H. B., Phesse, T. J., & Clarke, A. R. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2895 · Cited by 94
Lupeol inhibits proliferation of human prostate cancer cells by targeting -catenin signaling
Saleem, M., Murtaza, I., Tarapore, R. S., Suh, Y., Adhami, V. M., Johnson, J. J., Siddiqui, I. A., Khan, N., Asim, M., Hafeez, B. B., et al. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp044 · Cited by 94
Ohigashi, T., Mizuno, R., Nakashima, J., Marumo, K., & Murai, M. (2004) · The Prostate · doi:10.1002/pros.20117 · Cited by 93
Liao, X., Thrasher, J. B., Holzbeierlein, J. M., Stanley, S. D., & Li, B. (2004) · Endocrinology · doi:10.1210/en.2003-1519 · Cited by 92
A Direct β-Catenin-independent Interaction between Androgen Receptor and T Cell Factor 4
Amir, A. L., Barua, M., McKnight, N. C., Cheng, S., Yuan, X., & Balk, S. P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301208200 · Cited by 91
Horvath, L. G., Henshall, S. M., Kench, J. G., Saunders, D. N., Lee, C. S., Golovsky, D., Brenner, P. C., O’Neill, G., Kooner, R., Stricker, P. D., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0707-03 · Cited by 90
Chesire, D. R., Dunn, T. A., Ewing, C. M., Luo, J., & Isaacs, W. B. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3309 · Cited by 84
Wnt11 in 2011 – the regulation and function of a non‐canonical Wnt
Onganer, P. U., & Kypta, R. M. (2011) · Acta Physiologica · doi:10.1111/j.1748-1716.2011.02297.x · Cited by 83
Self-citationStem cells in prostate cancer: treating the root of the problem
Taylor, R. A., Toivanen, R., & Risbridger, G. P. (2010) · Endocrine Related Cancer · doi:10.1677/erc-10-0145 · Cited by 80
Masiello, D., Chen, S., Xu, Y., Verhoeven, M. C., Choi, E., Hollenberg, A. N., & Balk, S. P. (2004) · Molecular Endocrinology · doi:10.1210/me.2003-0436 · Cited by 79
Activation of β-Catenin Signaling in Androgen Receptor–Negative Prostate Cancer Cells
Wan, X., Liu, J., Lu, J.-F., Tzelepi, V., Yang, J., Starbuck, M. W., Diao, L., Wang, J., Efstathiou, E., Vazquez, E. S., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2521 · Cited by 79
Beildeck, M. E., Gelmann, E. P., & Stephen, W. B. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.02.001 · Cited by 77
Kallakury, B., Sheehan, C. E., & Ross, J. S. (2001) · Human Pathology · doi:10.1053/hupa.2001.26463 · Cited by 76
Synergistic Effects of Coactivators GRIP1 and β-Catenin on Gene Activation
Li, H., Kim, J. H., Koh, S. S., & Stallcup, M. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311374200 · Cited by 76
Chen, S., Wulf, G. M., Zhou, X. Z., Rubin, M. A., Lu, K. P., & Balk, S. P. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.3.929-939.2006 · Cited by 74
Alterations in β‐catenin expression and localization in prostate cancer
Whitaker, H. C., Girling, J., Warren, A. Y., Leung, H. Y., Mills, I. G., & Neal, D. E. (2008) · The Prostate · doi:10.1002/pros.20780 · Cited by 71
Li, Z. G., Yang, J., Vazquez, E. S., Rose, D., Vakar‐Lopez, F., Mathew, P. F., López, A., Logothetis, C. J., Lin, S.-H., & Navone, N. M. (2007) · Oncogene · doi:10.1038/sj.onc.1210694 · Cited by 69
Lower levels of nuclear β‐catenin predict for a poorer prognosis in localized prostate cancer
Horvath, L. G., Henshall, S. M., Lee, C. S., Kench, J. G., Golovsky, D., Brenner, P. C., O’Neill, G., Kooner, R., Stricker, P. D., Grygiel, J. J., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20599 · Cited by 67
Androgen regulation of the androgen receptor coregulators
Urbanucci, A., Waltering, K. K., Suikki, H. E., Helenius, M. A., & Visakorpi, T. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-219 · Cited by 63
Structural basis of coactivation of liver receptor homolog-1 by β-catenin
Yumoto, F., Nguyen, P., Sablin, E. P., Baxter, J. D., Webb, P., & Fletterick, R. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117036108 · Cited by 63
Does GSK-3 provide a shortcut for PI3K activation of Wnt signalling?
Voskas, D., Ling, L. S., & Woodgett, J. R. (2010) · F1000 Biology Reports · doi:10.3410/b2-82 · Cited by 61
Horvath, L. G., Lelliott, J. E., Kench, J. G., Lee, C. S., Williams, E. D., Saunders, D. N., Grygiel, J. J., Sutherland, R. L., & Henshall, S. M. (2007) · The Prostate · doi:10.1002/pros.20607 · Cited by 61
Wang, B.-E., Wang, X.-D., Ernst, J. A., Polakis, P. G., & Gao, W. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002186 · Cited by 60
Expression profile of WNT molecules in prostate cancer and its regulation by aminobisphosphonates
Thiele, S., Rauner, M., Goettsch, C., Rachner, T. D., Benad, P., Fuessel, S., Erdmann, K., Hamann, C., Baretton, G. B., Wirth, M. P., et al. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23070 · Cited by 55
Mutations in the AXIN1 Gene in Advanced Prostate Cancer
Yardy, G., Bicknell, D., Wilding, J. L., Bartlett, S., Liu, Y., WINNEY, B. J., Turner, G. D. H., BREWSTER, S. F., & Bodmer, W. F. (2008) · European Urology · doi:10.1016/j.eururo.2008.05.029 · Cited by 55
Khaja, A. S. S., Helczynski, L., Edsjö, A., Ehrnström, R. A., Lindgren, A., Ulmert, D., Andersson, T., & Bjartell, A. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026539 · Cited by 52
Interaction of β-Catenin and TIF2/GRIP1 in Transcriptional Activation by the Androgen Receptor
Song, L., & Gelmann, E. P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503850200 · Cited by 52
Takahashi, S., Watanabe, T., Okada, M., Inoue, K., Ueda, T., Takada, I., Watabe, T., Yamamoto, Y., Fukuda, T., Nakamura, T., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014850108 · Cited by 51
WNT5A selectively inhibits mouse ventral prostate development
Allgeier, S. H., Lin, T., Vezina, C. M., Moore, R. W., Fritz, W. A., Chiu, S. Y., Zhang, C., & Peterson, R. E. (2008) · Developmental Biology · doi:10.1016/j.ydbio.2008.08.018 · Cited by 48
Joesting, M. S., Cheever, T. R., Volzing, K., Yamaguchi, T. P., Wolf, V., Näf, D., Rubin, J. S., & Marker, P. C. (2008) · Developmental Biology · doi:10.1016/j.ydbio.2008.02.021 · Cited by 45
Kawano, Y., Diez, S., Onganer, P. U., Darrington, R. S., Waxman, J., & Kypta, R. M. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604976 · Cited by 44
Self-citationHall, C. L., Zhang, H., Baile, S., Ljungman, M. E., Kuhstoss, S. A., & Keller, E. T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0440 · Cited by 43
Liu, X., Kirschenbaum, A. M., Shen, Y., Liu, G., Aaronson, S. A., & Levine, A. C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0478 · Cited by 40
Winning WNT: Race to Wnt signaling inhibitors
Watanabe, K., & Dai, X. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103102108 · Cited by 37
Expression of b-Catenin in Prostatic Adenocarcinomas A Comparison With Colorectal Adenocarcinomas
Bismar, T. A., Humphrey, P. A., Grignon, D. J., & Wang, H. L. (2004) · American Journal of Clinical Pathology · doi:10.1309/4470-49gv-52h7-d258 · Cited by 32
The role of secreted frizzled-related protein 2 expression in prostate cancer
O’Hurley, G., Perry, A. S., O’Grady, A., Loftus, B. M., Smyth, P. C., O’Leary, J. J., Sheils, O. M., Fitzpatrick, J. M., Hewitt, S. M., Lawler, M., et al. (2011) · Histopathology · doi:10.1111/j.1365-2559.2011.04073.x · Cited by 29
Axin2 expression identifies progenitor cells in the murine prostate
Ontiveros, C. S., Salm, S. N., & Wilson, E. L. (2008) · The Prostate · doi:10.1002/pros.20770 · Cited by 21
The β-Catenin Binding Protein ICAT Modulates Androgen Receptor Activity
Zhuo, M., Zhu, C., Sun, J., Weis, W. I., & Sun, Z. (2011) · Molecular Endocrinology · doi:10.1210/me.2011-1023 · Cited by 18
Activation of Wnt Signaling by Chemically Induced Dimerization of LRP5 Disrupts Cellular Homeostasis
Shahi, P., Park, D., Pond, A. C., Seethammagari, M. R., Chiou, S., Cho, K., Carstens, J. L., Decker, W. K., McCrea, P. D., Ittmann, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030814 · Cited by 18
PTEN mutations do not cause nuclear β-catenin accumulation in endometrial carcinomas
Wappenschmidt, B., Wardelmann, E., Gehrig, A., Schöndorf, T., Maass, N., Bonatz, G., Gassel, A. M., Pietsch, T., Mallmann, P. K., Weber, B. H. F., et al. (2004) · Human Pathology · doi:10.1016/j.humpath.2004.06.007 · Cited by 15
Cited by
Karantanos, T., Corn, P. G., & Thompson, T. C. (2013) · Oncogene · doi:10.1038/onc.2013.206 · Cited by 866
lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs
Yang, L., Lin, C., Jin, C., Yang, J. C., Tanasa, B., Li, W., Merkurjev, D., Ohgi, K. A., Meng, D., Zhang, J., et al. (2013) · Nature · doi:10.1038/nature12451 · Cited by 657
Wnt signaling in stem and cancer stem cells
Holland, J. D., Klaus, A., Garratt, A. N., & Birchmeier, W. (2013) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2013.01.004 · Cited by 504
Wnt/β-catenin signaling pathway in carcinogenesis and cancer therapy
Song, P., Gao, Z., Bao, Y., Chen, L., Huang, Y., Liu, Y., Dong, Q., & Wei, X. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01563-4 · Cited by 382
WNT signalling in prostate cancer
Murillo-Garzón, V., & Kypta, R. (2017) · Nature Reviews Urology · doi:10.1038/nrurol.2017.144 · Cited by 361
Self-citation
Metadata
- Authors
- Kypta, R. M., & Waxman, J.
- Venue
- Nature Reviews Urology
- Published
- 2012-06-19
- Volume
- 9
- Issue
- 8
- Pages
- 418-428
- ISSN
- 1759-4812 (ISSN-L)
- 1759-4820
- OpenAlex
- W1969556504
- Cited by
- 275
- References
- 144
- FWCI
- 1.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.